Status:
UNKNOWN
Weathering the Storm: Lung, Heart, and Brain Vascular Rehabilitation for COVID-19
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
National Center for Advancing Translational Sciences (NCATS)
Conditions:
Covid19
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Background: Respiratory and cardiovascular complications have emerged as dominant threats during and following coronavirus disease (COVID19) infection. Severe COVID19 infection is categorized as acute...
Detailed Description
Aim 1 - Does individualized cardiac exercise rehabilitation enhance cardiorespiratory \& cerebrovascular recovery? It is widely accepted that "exercise is medicine"; a polypill and a cornerstone in th...
Eligibility Criteria
Inclusion
- BMI\<40,
- 1-4 weeks post active COVID19 infection
- physician approval for undertaking exercise testing and training.
- Adequate intracranial ultrasound windows
Exclusion
- Lingering COVID19 symptomology
- cardiovascular disease
- pulmonary disease
- cerebrovascular disease
- taking medication that influences heart rate, blood pressure, or cerebrovascular function,
- severe obesity (BMI \>40)
- metabolic comorbidities (diabetes, metabolic syndrome),
- recently been diagnosed with a mild traumatic brain injury (within past 6 months).
Key Trial Info
Start Date :
May 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04887272
Start Date
May 15 2021
End Date
November 30 2021
Last Update
May 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60612